Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 20 | 2 | 10 | 33 |
| Receivables | 0 | 0 | 2 | 100 | 5 |
| Inventories | 0 | 0 | 0 | 70 | 5 |
| TOTAL | $0 | $20 | $3 | $180 | $43 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 0 | 0 | 3 |
| Investments And Advances | 0 | 0 | 0 | 2 | 0 |
| Other Non-Current Assets | 0 | 0 | 60 | 20 | 30 |
| TOTAL | $0 | $0 | $60 | $22 | $33 |
| Total Assets | $0 | $20 | $110 | $220 | $179 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 4 | 2 | 5 | 5 |
| Accrued Expenses | 0 | 0 | 7 | 2 | 0 |
| TOTAL | $0 | $4 | $10 | $87 | $22 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 40 | 0 | 0 |
| TOTAL | $0 | $0 | $40 | $0 | $0 |
| Total Liabilities | $0 | $4 | $50 | $80 | $22 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 1,560 | 1,560 | 1,560 | 1,560 |
| Retained earnings | 0 | -3,200 | -3,160 | -3,090 | -3,068 |
| Other shareholders' equity | 0 | 10 | 10 | 10 | 14 |
| TOTAL | $0 | $20 | $60 | $130 | $156 |
| Total Liabilities And Equity | $0 | $24 | $110 | $210 | $179 |